UFP Technologies Form 4: Director Daniel C. Croteau reports two sales at $206
Rhea-AI Filing Summary
Daniel C. Croteau, a director of UFP Technologies, Inc. (UFPT), reported two open-market sales of common stock on 09/05/2025. The first sale reports 1,000 shares sold at $206.045 with 2,728 shares beneficially owned after that transaction. The second sale reports 1,873 shares sold at $206.00 with 855 shares beneficially owned after that transaction. The Form 4 was signed by an attorney-in-fact on 09/08/2025.
Positive
- Full disclosure of transactions with prices and post-transaction holdings provided
- Form filed by one reporting person and signed by an attorney-in-fact, indicating procedural completion
Negative
- None.
Insights
TL;DR: Insider director executed two sizable stock sales at ~$206 per share, reducing reported direct holdings to 855 shares.
The transactions are routine open-market dispositions by a director, executed on 09/05/2025. Reported sale prices are $206.045 and $206.00 for 1,000 and 1,873 shares respectively. The filings show post-transaction beneficial ownership of 2,728 shares after the first reported sale and 855 shares after the second. No derivatives or other transactions are reported.
TL;DR: Form 4 properly discloses two Section 16 dispositions and is signed via attorney-in-fact.
The Form 4 lists the reporter as a director and indicates individual filing by one reporting person. The signature block shows filing by an attorney-in-fact (Patrick J. Kinney, Jr.) dated 09/08/2025. The form discloses two sale ("S") codes for common stock and provides post-transaction direct ownership figures. There are no amendment flags or derivative transactions disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $.01 Par Value | 1,000 | $206.045 | $206K |
| Sale | Common Stock, $.01 Par Value | 1,873 | $206.00 | $386K |
Footnotes (1)
FAQ
What trades did Daniel C. Croteau report on Form 4 for UFPT?
Was the Form 4 filed jointly or individually?
Who signed the Form 4 and when?
Were any derivative securities reported on this Form 4?